HIV reservoirs and immune surveillance evasion cause the failure of structured treatment interruptions: a computational study.

PloS One
Emiliano ManciniPeter M A Sloot

Abstract

Continuous antiretroviral therapy is currently the most effective way to treat HIV infection. Unstructured interruptions are quite common due to side effects and toxicity, among others, and cannot be prevented. Several attempts to structure these interruptions failed due to an increased morbidity compared to continuous treatment. The cause of this failure is poorly understood and often attributed to drug resistance. Here we show that structured treatment interruptions would fail regardless of the emergence of drug resistance. Our computational model of the HIV infection dynamics in lymphoid tissue inside lymph nodes, demonstrates that HIV reservoirs and evasion from immune surveillance themselves are sufficient to cause the failure of structured interruptions. We validate our model with data from a clinical trial and show that it is possible to optimize the schedule of interruptions to perform as well as the continuous treatment in the absence of drug resistance. Our methodology enables studying the problem of treatment optimization without having impact on human beings. We anticipate that it is feasible to steer new clinical trials using computational models.

References

Sep 6, 2001·Computers in Biology and Medicine·M Bernaschi, F Castiglione
Oct 6, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A LafeuilladeC Poggi
Nov 3, 2001·Physical Review Letters·R M Zorzenon dos Santos, S Coutinho
Oct 3, 2003·AIDS·Jintanat AnanworanichUNKNOWN Swiss HIV Cohort Study
Mar 24, 2004·Nature Reviews. Microbiology·Viviana Simon, David D Ho
Jan 15, 2005·AIDS Research and Human Retroviruses·Filippo CastiglioneMassimo Bernaschi
Dec 1, 2006·The New England Journal of Medicine·UNKNOWN Strategies for Management of Antiretroviral Therapy (SMART) Study GroupC Rappoport
May 13, 1983·Science·S KirkpatrickM P Vecchi
Dec 18, 2007·Journal of Theoretical Biology·Veronica ShiYang Kuang
May 14, 2008·The Journal of Infectious Diseases·UNKNOWN Strategies for Management of Antiretroviral Therapy (SMART) Study GroupAndrew N Phillips
Sep 2, 2008·Bulletin of Mathematical Biology·E G BurkheadD K Molinek
Apr 3, 2009·The New England Journal of Medicine·Mari M KitahataUNKNOWN NA-ACCORD Investigators
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Simone PensierosoPaolo Rossi
Aug 17, 2010·PLoS Computational Biology·Sharon AviranAdam P Arkin
Sep 10, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Katharina KranzerRobin Wood
Oct 7, 2010·Cancer Research·Arianna PalladiniPier-Luigi Lollini
Mar 3, 2011·BMC Infectious Diseases·Paola PaciFilippo Castiglione
Jul 2, 2011·Tropical Medicine & International Health : TM & IH·Katharina Kranzer, Nathan Ford
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Sep 9, 2011·Computer Methods and Programs in Biomedicine·Jorge FerreiraRichard H Middleton
Sep 16, 2011·The Journal of Infectious Diseases·Sidonie Lambert-NiclotAnne-Genevieve Marcelin
Dec 14, 2011·Current Opinion in HIV and AIDS·Marc P Girard, Stanley A Plotkin

❮ Previous
Next ❯

Software Mentioned

Dybul
ImmSim

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Bulletin of the World Health Organization
Kevin M De CockBrian G Williams
Sexually Transmitted Diseases
Mina C Hosseinipour, Nora E Rosenberg
The Lancet Oncology
Michael J SilverbergDonald I Abrams
© 2021 Meta ULC. All rights reserved